PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l\'Hôpital, 67000, Strasbourg, France.\', \'INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France.\', \'Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 1 place de l\'Hôpital, 67000, Strasbourg, France. olivier.morel@chru-strasbourg.fr.\', \'INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, 67000, Strasbourg, France. olivier.morel@chru-strasbourg.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s11239-020-02231-3
?:doi
?:hasPublicationType
?:journal
  • Journal of thrombosis and thrombolysis
is ?:pmid of
?:pmid
?:pmid
  • 32696172
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.991
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all